To evaluate the role of Jdp2 in tumor maintenance we used an shRNA construct to knockdown the levels of Jdp2 in a Dnmt3a-deficient MYC-induced PTCL cell line. The gene discussed is JDP2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.